Martek Biosciences---- future biotech cash cow! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Martek Biosciences---- future biotech cash cow!

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Asymmetric who wrote (8)	3/6/1996 10:28:00 AM
From: bill small	of 258

Peter, some news There was a blub in today's local paper re Martek. Said they narrowed the loss in the first quarter ended 31 Jan 96 to $44,000 from a year ago $2.2M. CEO is quoted as ..."stronger financial results are due in part to a deal Martek struck with Sandoz Nutrition SA to be the sixth licensee for Martek's Formulaid product, an infant formula additive. The company also improved production efficiency for its DHA and ARA oils, which are used in Formulaid." This confirms the news about progress I have previously posted. I would imagine there is a news release out on this but I haven't seen it. best........Bill

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next